vorinostat has been researched along with Laryngeal Neoplasms in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yuan, H | 1 |
| Myers, S | 1 |
| Wang, J | 1 |
| Zhou, D | 1 |
| Woo, JA | 1 |
| Kallakury, B | 1 |
| Ju, A | 1 |
| Bazylewicz, M | 1 |
| Carter, YM | 1 |
| Albanese, C | 1 |
| Grant, N | 1 |
| Shad, A | 1 |
| Dritschilo, A | 1 |
| Liu, X | 1 |
| Schlegel, R | 1 |
1 other study available for vorinostat and Laryngeal Neoplasms
| Article | Year |
|---|---|
Use of reprogrammed cells to identify therapy for respiratory papillomatosis.
Topics: Antineoplastic Agents; Cells, Cultured; DNA, Viral; Gene Expression; Genome, Viral; Human papillomav | 2012 |